Schroder Investment Management Group
NGNE icon

Schroder Investment Management Group’s Neurogene NGNE Stock Holding History

Schroder Investment Management Group’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Hold
52,300
– – ﹤0.01% 958
2026
Q1 		$1.01M Hold
52,300
– – ﹤0.01% 1027
2025
Q4 		$1.16M Buy
52,300
+22,123
+73% +$551K ﹤0.01% 971
2025
Q3 		$534K Hold
30,177
– – ﹤0.01% 1086
2025
Q2 		$451K Buy
+30,177
New +$474K ﹤0.01% 1063

Other funds holding NGNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Schroder Investment Management Group's NGNE Position: Q2 2026 in Review

Schroder Investment Management Group held its Neurogene (NGNE) position steady in Q2 2026 at 52,300 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #958.

Schroder Investment Management Group first reported a position in NGNE in Q2 2025 and has held it in 5 quarters since. 68 funds tracked by Wall St. Rank hold NGNE as of Q2 2026.

  • Schroder Investment Management Group held 52,300 shares of Neurogene worth $1.69M as of Q2 2026.
  • Schroder Investment Management Group left its Neurogene share count unchanged in Q2 2026.
  • Neurogene made up ﹤0.01% of Schroder Investment Management Group's portfolio in Q2 2026, its #958 holding.
  • Schroder Investment Management Group first reported a position in Neurogene in Q2 2025 and has held it in 5 quarters since.
  • 68 funds tracked by Wall St. Rank held Neurogene as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.